Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 72, Issue 8, Pages 1473-1488Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-014-1808-8
Keywords
Resveratrol; Sirt1; PDE4; AMPK
Categories
Funding
- Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006118, Z01HL002243] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Resveratrol, a polyphenol found in a number of plant-based foods such as red wine, has received a great deal of attention for its diverse array of healthful effects. Beneficial effects of resveratrol are diverse; they include improvement of mitochondrial function, protection against obesity and obesity-related diseases such as type-2 diabetes, suppression of inflammation and cancer cell growth and protection against cardiovascular dysfunction, just to name a few. Investigations into the metabolic effects of resveratrol are furthest along and now include a number of clinical trials, which have yielded mixed results. There are a number of controversies surrounding resveratrol that have not been resolved. Here, we will review these controversies with particular emphasis on its mechanism of metabolic action and how lessons from resveratrol may help develop therapies that harness the effects of resveratrol but without the undesirable properties of resveratrol.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available